Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers EC Page, EK Bancroft, MN Brook, M Assel, MH Al Battat, S Thomas, ... European urology 76 (6), 831-842, 2019 | 217 | 2019 |
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study EK Bancroft, EC Page, MN Brook, S Thomas, N Taylor, J Pope, J McHugh, ... The lancet oncology 22 (11), 1618-1631, 2021 | 62 | 2021 |
SERS of cells: What can we learn from cell lysates? E Genova, M Pelin, G Decorti, G Stocco, V Sergo, A Ventura, A Bonifacio Analytica Chimica Acta 1005, 93-100, 2018 | 34 | 2018 |
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples S Fornasaro, E Gurian, S Pagarin, E Genova, G Stocco, G Decorti, ... Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 246, 119024, 2021 | 23 | 2021 |
Induced pluripotent stem cells for therapy personalization in pediatric patients: focus on drug-induced adverse events E Genova, F Cavion, M Lucafò, L De Leo, M Pelin, G Stocco, G Decorti World journal of stem cells 11 (12), 1020, 2019 | 20 | 2019 |
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients E Genova, F Cavion, M Lucafò, M Pelin, G Lanzi, S Masneri, RM Ferraro, ... Clinical Pharmacology & Therapeutics 108 (2), 358-367, 2020 | 10 | 2020 |
Induced pluripotent stem cells as a model for therapy personalization of pediatric patients: disease modeling and drug adverse effects prevention E Genova, M Pelin, K Sasaki, F Yue, G Lanzi, S Masneri, A Ventura, ... Current medicinal chemistry 25 (24), 2826-2839, 2018 | 9 | 2018 |
Assessing the clinical utility of genetic risk scores for targeted cancer screening CA Conran, Z Shi, WK Resurreccion, R Na, BT Helfand, E Genova, ... Journal of Translational Medicine 19, 1-9, 2021 | 7 | 2021 |
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay M Pelin, E Genova, L Fusco, M Marisat, U Hofmann, D Favretto, M Lucafò, ... Chemico-Biological Interactions 275, 189-195, 2017 | 4 | 2017 |
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells E Genova, M Lucafò, M Pelin, V Di Paolo, L Quintieri, G Decorti, G Stocco Chemico-Biological Interactions 347, 109624, 2021 | 3 | 2021 |
In vitro effects of sulforaphane on interferon-driven inflammation and exploratory evaluation in two healthy volunteers E Genova, M Apollonio, G Decorti, A Tesser, A Tommasini, G Stocco Molecules 26 (12), 3602, 2021 | 3 | 2021 |
Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis E Genova, G Stocco, G Decorti World Journal of Gastroenterology 27 (35), 5796, 2021 | 2 | 2021 |
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease G Lanzi, S Masneri, RM Ferraro, E Genova, G Piovani, C Barisani, M Pelin, ... Stem Cell Research 40, 101548, 2019 | 2 | 2019 |
Induced pluripotent stem cells to model adverse drug reactions in pediatric patients E Genova, G Stocco, G Decorti Pharmacogenomics 21 (14), 975-978, 2020 | | 2020 |
Induced pluripotent stem cells as an innovative model for therapy personalization of inflammatory bowel disease. E Genova Università degli Studi di Trieste, 2020 | | 2020 |
BIOMARKERS AND PRECISION THERAPY FOR PRIMARY IMMUNODEFICIENCIES: AN EX VIVO STUDY IN INDUCIBLE PLURIPOTENT STEM CELLS FROM PATIENTS. E Genova, F Cavion, M Lucafo, M Pelin, A Tesser, E Piscianz, G Lanzi, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S72-S73, 2019 | | 2019 |
SERS of cells: What can we learn from cell lysates? V SERGO, G STOCCO, G DECORTI, A VENTURA, M PELIN, ... | | |
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay A VENTURA, G STOCCO, S MARTELOSSI, M PELIN, D FAVRETTO, ... | | |